NEW YORK (360Dx) – MdxHealth announced today that it has entered into an agency service agreement with Unilabs for MDxHealth's SelectMDx urine test for prostate cancer.

Under the terms of the agreement, Unilabs will offer SelectMDx to patients of all its clinical labs in France, Portugal, Sweden, Norway, Denmark, Finland, UK, Italy, and Switzerland. Unilabs' medical laboratory in Geneva will perform the SelectMDx service testing. To offer the service throughout its network, Unilabs will purchase SelecMDx CE-market IVD kits from MDxHealth.

To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have a 360Dx or GenomeWeb account?
Login Now.